Prevalence, risk factors and outcome of hyperlactataemia in HIV-infected patients

L Hocqueloux1, C Alberti, J-P Feugeas

  • 1Clinique des Maladies Infectieuses, Département de Biostatistique et Informatique Médicale, Laboratoire de Biochimie B, Hôpital Saint-Louis, Paris, France.

HIV Medicine
|January 22, 2003
PubMed

Insights

Hyperlactataemia (HL) in HIV patients is linked to nucleoside reverse transcriptase inhibitors (NRTIs), particularly didanosine and stavudine. Discontinuing NRTIs can help resolve HL, which rarely leads to lactic acidosis or poorer outcomes.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Biochemistry

Background:

  • Hyperlactataemia (HL) is a potential complication in HIV-infected patients.
  • Understanding the prevalence, risk factors, and outcomes of HL is crucial for patient management.

Purpose of the Study:

  • To determine the prevalence, risk factors, and clinical outcomes of hyperlactataemia in a cohort of HIV-infected patients.
  • To investigate the association between HL and antiretroviral therapy, specifically nucleoside reverse transcriptase inhibitors (NRTIs).

Main Methods:

  • A cohort of 140 HIV-infected patients had venous plasma lactate levels measured.
  • HL was defined as two consecutive lactate levels > 2.1 mmol/L.
  • Demographic, immuno-virological, and antiretroviral therapy data were compared between patients with and without HL.

Main Results:

  • Hyperlactataemia was found in 8.5% of patients, all receiving NRTIs.
  • Didanosine and stavudine were significantly associated with HL.
  • Discontinuation of NRTIs led to lactate level normalization in most cases.

Conclusions:

  • HL is associated with NRTI use, especially didanosine and stavudine.
  • Discontinuation of NRTIs appears to facilitate the resolution of HL.
  • Lactic acidosis is rare, and long-term outcomes for patients with HL are comparable to controls.
Abstract

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...